Phase II study of topotecan and cyclophosphamide in patients with relapsed and refractory multiple myeloma.
Kraut
Eric H
EH
Young
Donn
D
Farag
Sherif
S
James
Arthur G
AG
Solove
Richard J
RJ
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D016879:Salvage Therapy; D019772:Topotecan / Q000008:administration & dosage; D017211:Treatment Failure
D019772:Topotecan; D003520:Cyclophosphamide